The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Genome changes and gene expression in human solid tumors
Abstract
Genome-wide analysis techniques such as chromosome painting, comparative genomic hybridization, representational difference analysis, restriction landmark genome scanning and high-throughput analysis of LOH are now accelerating high-resolution genome aberration localization in human tumors. These techniques are complemented by procedures for detection of differentially expressed genes such as differential display, nucleic acid subtraction, serial analysis of gene expression and expression microarray analysis. These efforts are enabled by work from the human genome program in physical map development, cDNA library production/sequencing and in genome sequencing. This review covers several commonly used large-scale genome and gene expression analysis techniques, outlines genomic approaches to gene discovery and summarizes information that has come from large-scale analyses of human solid tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Disruption of p53 in human cancer cells alters the responses to therapeutic agents.
Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6863 · Cited by 1,044
Chromosome painting: a useful art
Ried, T. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.10.1619 · Cited by 154
Cited by
The Transcriptome of the Intraerythrocytic Developmental Cycle of Plasmodium falciparum
Bozdech, Z., Llinás, M., Pulliam, B. L., Wong, E. D., Zhu, J., & DeRisi, J. L. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000005 · Cited by 1,728
Biomarkers in Cancer Staging, Prognosis and Treatment Selection
Ludwig, J. A., & Weinstein, J. N. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1739 · Cited by 1,666
Ovarian cancer: strategies for overcoming resistance to chemotherapy
Agarwal, R., & Kaye, S. B. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1123 · Cited by 1,154
DePinho, R. A. (2000) · Nature · doi:10.1038/35041694 · Cited by 951
“The spontaneous loss of function, or perhaps haploinsufficiency, in these genome maintenance pathways might also provide a basis for the well-recognized inherent instability of tumour cell genomes relative to their normal counterpart”
BackgroundCentrosome aberrations: cause or consequence of cancer progression?
Nigg, E. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc924 · Cited by 732
Defying death after DNA damage
Rich, T., Allen, R. L., & Wyllie, A. H. (2000) · Nature · doi:10.1038/35037717 · Cited by 724
(EFSA), E. F. S. A. (2005) · EFSA Journal · doi:10.2903/j.efsa.2005.282 · Cited by 582
The genetics and genomics of cancer
Balmain, A., Gray, J., & Ponder, B. (2003) · Nature Genetics · doi:10.1038/ng1107 · Cited by 573
Self-citationConnecting Chromosomes, Crisis, and Cancer
Maser, R. S., & DePinho, R. A. (2002) · Science · doi:10.1126/science.297.5581.565 · Cited by 561
High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping
Peiffer, D. A., Le, J. M., Steemers, F. J., Chang, W., Jenniges, T., Garcia, F., Haden, K., Li, J., Shaw, C. A., Belmont, J., et al. (2006) · Genome Research · doi:10.1101/gr.5402306 · Cited by 519
Cancer and ageing: rival demons?
Campisi, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1073 · Cited by 512
A compendium of gene expression in normal human tissues
HSIAO, L.-L., DANGOND, F., YOSHIDA, T., HONG, R., JENSEN, R. V., MISRA, J., DILLON, W., LEE, K. F., CLARK, K. E., HAVERTY, P., et al. (2001) · Physiological Genomics · doi:10.1152/physiolgenomics.00040.2001 · Cited by 503
Coppé, J.-P., Patil, C. K., Rodier, F., Krtolica, A., Beauséjour, C. M., Parrinello, S., Hodgson, J. G., Chin, K., Desprez, P.-Y., & Campisi, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009188 · Cited by 455
“CGH analyses were carried out essentially as previously described [53].”
MethodPonder, B. A. J. (2001) · Nature · doi:10.1038/35077207 · Cited by 446
Cellular senescence: a link between cancer and age-related degenerative disease?
Campisi, J., Andersen, J. K., Kapahi, P., & Melov, S. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.001 · Cited by 421
“Cancer cells typically harbor many dozens of genomic alterations [7], the acquisition of which is often accelerated by early mutations that inactivate genes that are critical for maintaining genomic stability [8].”
BackgroundCellular senescence, cancer and aging: the telomere connection
Campisi, J., Kim, S.-H., Lim, C.-S., & Rubio, M. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00160-7 · Cited by 400
DNA Microarrays in Clinical Oncology
Ramaswamy, S., & Golub, T. R. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.7.1932 · Cited by 379
Pinard, R., de Winter, A., Sarkis, G. J., Gerstein, M. B., Tartaro, K. R., Plant, R. N., Egholm, M., Rothberg, J. M., & Leamon, J. H. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-216 · Cited by 318
Cancer and aging: a model for the cancer promoting effects of the aging stroma
Krtolica, A., & Campisi, J. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00053-5 · Cited by 295
Chromosomal biomarkers of genomic instability relevant to cancer
Fenech, M. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02502-3 · Cited by 281
Cancer and aging: the importance of telomeres in genome maintenance
Rodier, F., Kim, S.-H., Nijjar, T., Yaswen, P., & Campisi, J. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.012 · Cited by 132
“These genomic changes, in turn, can drive both cancer and aging phenotypes [2-4, 32, 33].”
BackgroundTelomere shortening and cell fates in mouse models of neoplasia
Artandi, S. E. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02222-5 · Cited by 40
Metadata
- Authors
- Gray, J. W., & Collins, C.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-03
- Volume
- 21
- Issue
- 3
- Pages
- 443-452
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2152365292
- Cited by
- 193
- References
- 2
- FWCI
- 13.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.